Carolyn Bertozzi

Carolyn Bertozzi
Name	Carolyn Bertozzi
Birth date	1966-10-10
Birth place	Boston, Massachusetts
Nationality	American
Fields	Chemistry, Chemical Biology
Alma mater	Harvard University, University of California, Berkeley
Doctoral advisor	Mark D. Bednarski
Known for	Bioorthogonal chemistry, Glycobiology
Awards	Nobel Prize in Chemistry, MacArthur Fellowship, National Medal of Science

Carolyn Bertozzi is an American chemist and chemical biologist noted for pioneering bioorthogonal chemistry and advancing glycobiology, chemical imaging, and targeted therapeutics. Her work bridges academic institutions such as Harvard University, Stanford University, and University of California, Berkeley with industry partners including Genentech, Pfizer, and biotechnology startups. Bertozzi's research has influenced fields represented by organizations like National Institutes of Health, Howard Hughes Medical Institute, and National Science Foundation.

Early life and education

Bertozzi was born in Boston, Massachusetts, and raised in the context of scientific communities connected to institutions such as Massachusetts Institute of Technology, Harvard Medical School, and Boston University. She attended Harvard University for undergraduate studies, where interactions with faculty linked to American Chemical Society, Phi Beta Kappa, and laboratories associated with Harvard College shaped her trajectory. For graduate studies she trained at University of California, Berkeley under advisors connected to programs at Lawrence Berkeley National Laboratory and collaborations with researchers from Stanford University School of Medicine and California Institute of Technology.

Research and scientific contributions

Bertozzi developed and popularized bioorthogonal chemistry, a toolkit enabling chemical reactions to occur inside living systems without interfering with native biochemical processes; this work interacts with methodologies from glycobiology, chemical biology, biochemistry, and technologies used at Scripps Research Institute, Whitehead Institute, and Cold Spring Harbor Laboratory. Her research on cell-surface glycans informed studies at Broad Institute, Massachusetts General Hospital, and Dana–Farber Cancer Institute by enabling imaging techniques compatible with magnetic resonance imaging, fluorescence microscopy, and electron microscopy. She advanced therapeutic approaches including antibody–drug conjugates and targeted drug delivery studied at Genentech, Roche, and Amgen, and contributed to understanding immune checkpoint pathways relevant to National Cancer Institute initiatives and collaborations with Memorial Sloan Kettering Cancer Center. Her laboratory's innovations intersect with chemical probes used in research at University of Cambridge, Max Planck Society, and Institut Pasteur.

Academic and professional career

Bertozzi held faculty positions at institutions such as University of California, Berkeley, where she contributed to departments interacting with Lawrence Berkeley National Laboratory and the Howard Hughes Medical Institute, and later at Stanford University, linking to programs at Stanford University School of Medicine and Stanford Cancer Institute. She joined Harvard University as a professor and led laboratories collaborating with Broad Institute, Massachusetts Institute of Technology, and Brigham and Women's Hospital. She served on advisory boards for companies including Enable Biosciences and PureTech Health and on panels for agencies such as National Institutes of Health and National Science Foundation. Her roles included mentoring trainees who moved to positions at Yale University, Princeton University, Columbia University, and University of California, San Francisco.

Awards and honors

Bertozzi's recognitions include the Nobel Prize in Chemistry, the MacArthur Fellowship, the National Medal of Science, and membership in organizations like the National Academy of Sciences, the American Academy of Arts and Sciences, and the Royal Society. She received prizes such as the Royal Society of Chemistry's Centenary Prize, the Wolf Prize in Chemistry, and awards from American Chemical Society divisions and foundations linked to Guggenheim Foundation and Simons Foundation. Honorary degrees and lectureships connected her to universities including University of Oxford, University of Cambridge, and Yale University.

Personal life and advocacy

Bertozzi has participated in advocacy and public engagement with organizations like American Association for the Advancement of Science, Society for Neuroscience, and Women in Chemistry initiatives; she has spoken at conferences hosted by TED, AAAS Annual Meeting, and Nobel Laureate Meetings. She has engaged in mentorship programs tied to Howard Hughes Medical Institute and diversity efforts promoted by National Institutes of Health and American Chemical Society. Media appearances and interviews have been featured in outlets collaborating with Nature, Science (journal), and The New York Times.

Selected publications and patents

Representative publications appear in journals such as Nature, Science (journal), Cell (journal), Journal of the American Chemical Society, and Proceedings of the National Academy of Sciences. Key papers describe bioorthogonal reactions, metabolic labeling of glycans, and applications in imaging and therapeutics, and patents have been filed with assignees including University of California, Stanford University, and biotechnology companies formed with partners from Genentech and Pfizer. Selected works include high-impact articles and reviews that have been cited across literature indexed by Web of Science, Scopus, and PubMed Central.

Category:American chemists Category:Nobel laureates in Chemistry